Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_assertion type Assertion NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_head.
- NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_assertion wasGeneratedBy ECO_0000203 NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_provenance.
- NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_assertion wasDerivedFrom befree-2016 NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_provenance.
- NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_assertion SIO_000772 17616668 NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_provenance.
- NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_assertion evidence source_evidence_literature NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_provenance.
- NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_assertion description "[Finally, treatment of glioma cell lines with prostaglandin E2, the predominant product of COX-2 activity, results in increased vascular endothelial growth factor expression, thus potentially linking elevations in COX-2 expression with tumor angiogenesis in malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618948.RAcwGSc2Yf_664sF-VftBhRR96LjdRVVitzRUF5NsUd6M130_provenance.